Nunzio Pagano
Internal Medicine · Asheville, NCNPI 1346539871
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 513 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 10.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,253 and has fallen 98.1% since, to $42 in 2023. Among internal medicine clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 513 payments — averaging $14.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$768
- AbbVie$706
- Amgen$609
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$605
- Pfizer$548
- Johnson & Johnson$504
- plus $4K from 24 others
What the payments were for
- Food & beverage$7,389100%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 59 | $768 |
| AbbVie(2 entities) | 47 | $706 |
| Amgen | 44 | $609 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 38 | $605 |
| Pfizer | 43 | $548 |
| Johnson & Johnson | 43 | $504 |
| Boehringer Ingelheim | 42 | $487 |
| Lilly USA, LLC | 26 | $414 |
| Novartis | 18 | $341 |
| GSK | 24 | $302 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $298 |
| Amarin Pharma, Inc. | 12 | $251 |
| AstraZeneca | 15 | $204 |
| Sanofi-aventis U.S. LLC | 9 | $202 |
| Bayer | 11 | $199 |
| Ironwood Pharmaceuticals, Inc | 10 | $148 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $136 |
| Merck | 9 | $128 |
| Abbott | 5 | $100 |
| Astellas Pharma US Inc | 6 | $90 |
| Kowa Pharmaceuticals America, Inc. | 5 | $68 |
| Esperion Therapeutics, Inc. | 3 | $55 |
| Eisai Inc. | 4 | $53 |
| Almatica Pharma LLC | 3 | $43 |
| Biohaven Pharmaceuticals, Inc. | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Aytu Biopharma, Inc. | 2 | $29 |
| Gilead | 1 | $24 |
| Tactile Systems Technology Inc | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
How this compares
$7,407 in reported general payments places this provider in the 90th percentile of 3,302 internal medicine providers in North Carolina.
Other internal medicine in Asheville
- Nirmish ShahDurham$862K
- Eugene WrightFayetteville$839K
- Saad UsmaniCharlotte$551K
- Bhakti PaulRaleigh$536K
- Mary KlotmanDurham$478K
- Manesh PatelDurham$435K
- Millie LongChapel Hill$374K
- Marc JohnsonCharlotte$342K
- Christina CraterRaleigh$330K
- Jamy ArdWinston Salem$293K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.